Last reviewed · How we verify
Chondroitin Sulphate (CHONDROITIN SULFATE)
Chondroitin Sulphate works by interacting with proteoglycans in the eye to facilitate surgical procedures.
Chondroitin Sulphate is a small molecule drug in the chondroitin sulfate class, originally developed by an unknown entity. It is currently used for surgical procedures on the eye, such as operation on the lens. The commercial status of Chondroitin Sulphate is unclear, with unknown patent status and generic manufacturers. Key safety considerations are not well-documented. Further research is needed to fully understand its pharmacology and clinical applications.
At a glance
| Generic name | CHONDROITIN SULFATE |
|---|---|
| Drug class | chondroitin sulfate |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | discontinued |
Mechanism of action
Imagine your body's tissues are like a complex web of fibers. Chondroitin Sulphate helps surgeons navigate and repair this web by interacting with the fibers, making it easier to perform delicate eye surgeries.
Approved indications
- Operation on lens
- Surgical procedure on eye proper
Common side effects
Key clinical trials
- Early vs Delayed Intravesical Blad-Care During BCG Therapy (NA)
- A Decentralized Clinical Study Evaluating the Effectiveness of Two Different Doses of MyCondro™ on Physical Mobility and Joint Health (NA)
- "Intra-articular Hyaluronic Acid Injection for Accelerating Functional Recovery After Knee Arthroscopy" (NA)
- Evaluating the Efficacy of FoundationDRS Solo in Addition to Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers (NA)
- Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye. (PHASE4)
- Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC (PHASE1,PHASE2)
- A Clinical Study to Evaluate the Efficacy of Native CT-II® in Individuals With Knee Osteoarthritis (NA)
- Colorectal Omics and ofCS Proteoglycans (COCO) in Screening and a Diagnostic Pathway
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Chondroitin Sulphate CI brief — competitive landscape report
- Chondroitin Sulphate updates RSS · CI watch RSS